Bioactivation of dapsone to a cytotoxic metabolite: in vitro use of a novel two compartment system which contains human tissues.

1. A two compartment system, comprising two adjacent teflon chambers separated by a semi-permeable membrane, has been devised with which to investigate the generation of drug metabolites that are toxic to human cells in vitro. 2. Compartment A contained a drug-metabolising system (human liver microsomes +/- NADPH) and compartment B contained target cells (human mononuclear leucocytes). The semi-permeable membrane retained protein (m.w. greater than 10,000) but allowed equilibration (within 1 h) of drug and drug metabolites, during which time cells remained viable. 3. Incubation of dapsone (100 microM) with human microsomal protein (2 mg ml-1) and NADPH (1 mM) in compartment A caused cell death (8.7 +/- 1.8%) in compartment B, which was reduced significantly (P less than 0.05) by the addition of glutathione (500 microM). Dapsone in the absence of NADPH was not cytotoxic. 4. Chemical analysis showed the presence of dapsone hydroxylamine as the only stable metabolite in both compartment A (5.2 +/- 0.4% incubated drug) and compartment B (3.5 +/- 0.5%). 5. Irreversible binding of dapsone to cells was significantly (P less than 0.05) reduced by omission of NADPH (85 +/- 13 pmol/10(6) cells) or addition of glutathione (103 +/- 9) compared with control values (153 +/- 51).

[1]  J. Uetrecht,et al.  Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells. , 1988, The Journal of pharmacology and experimental therapeutics.

[2]  T. Monks,et al.  Detection and half-life of bromobenzene-3,4-oxide in blood. , 1984, Xenobiotica; the fate of foreign compounds in biological systems.

[3]  S. Spielberg,et al.  Acetaminophen toxicity in human lymphocytes in vitro. , 1980, The Journal of pharmacology and experimental therapeutics.

[4]  D. Grant,et al.  Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. , 1986, Annals of internal medicine.

[5]  W. C. Smith.  Are hypersensitivity reactions to dapsone becoming more frequent? , 1988, Leprosy review.

[6]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.

[7]  Spielberg Sp.  In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans. , 1984 .

[8]  A. R. Torkelson,et al.  Tissue culture cytotoxicity assay for cyclophosphamide metabolites in rat body fluids. , 1978, Journal of pharmaceutical sciences.

[9]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[10]  B. Ames,et al.  Revised methods for the Salmonella mutagenicity test. , 1983, Mutation research.

[11]  S. Spielberg,et al.  In vitro evaluation of a toxic metabolite of sulfadiazine. , 1985, Canadian journal of physiology and pharmacology.

[12]  N. Kitteringham,et al.  A comparative study oftheformation ofchemically reactive drugmetabolites byhumanliver microsomes , 1988 .

[13]  A. Bøyum.  Separation of lymphocytes, granulocytes, and monocytes from human blood using iodinated density gradient media. , 1984, Methods in enzymology.

[14]  A. Breckenridge,et al.  Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes. , 1989, British journal of clinical pharmacology.

[15]  J. Oliver,et al.  Oxidative Damage to Neutrophils in Glutathione Synthetase Deficiency , 1979, British journal of haematology.

[16]  T. Monks,et al.  Intra- and extra-cellular formation of metabolites from chemically reactive species. , 1984, Biochemical Society transactions.

[17]  M. P. Brown,et al.  In Vitro Inhibition of Granulopoiesis by 4‐Amino‐4′‐Hydroxylaminodiphenyl Sulfone , 1980, British journal of haematology.

[18]  J. Vaught,et al.  Studies of the metabolism of dapsone in man and experimental animals: formation of N-hydroxy metabolites. , 1973, The Journal of pharmacology and experimental therapeutics.

[19]  N. Kitteringham,et al.  A comparative study of the formation of chemically reactive drug metabolites by human liver microsomes. , 1988, British journal of clinical pharmacology.

[20]  B. Ames,et al.  Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. , 1975, Mutation research.

[21]  J. Thénot,et al.  Toxic agents resulting from the oxidative metabolism of steroid hormones and drugs. , 1978, Journal of toxicology and environmental health.

[22]  D. Liebler,et al.  Formation of glutathione conjugates by reactive metabolites of vinylidene chloride in microsomes and isolated hepatocytes. , 1985, Cancer research.

[23]  A. Ognibene.  Agranulocytosis due to dapsone. , 1970, Annals of internal medicine.

[24]  M. Balls,et al.  A comparison of two cytotoxicity assays for the detection of metabolism-mediated toxicity in vitro: a study with cyclophosphamide. , 1985, Xenobiotica; the fate of foreign compounds in biological systems.

[25]  D. Rassin,et al.  A method for measurement of free and bound plasma cyst(e)ine. , 1981, Analytical biochemistry.

[26]  B. K. Park,et al.  The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites. , 1987, British journal of clinical pharmacology.

[27]  A. Glazko,et al.  The polymorphic acetylation of dapsone in man , 1971, Clinical pharmacology and therapeutics.

[28]  A. Pegg,et al.  Alkylation of intracellular and extracellular DNA by dimethylnitrosamine following activation by isolated rat hepatocytes. , 1981, Cancer research.

[29]  N. Ziats,et al.  In vitro and in vivo interactions of cells with biomaterials. , 1988, Biomaterials.

[30]  N. Kitteringham,et al.  An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin. , 1988, British journal of clinical pharmacology.

[31]  T. Monks,et al.  Diffusion of reactive metabolites out of hepatocytes: studies with bromobenzene. , 1984, The Journal of pharmacology and experimental therapeutics.

[32]  D. Acosta,et al.  Metabolic activation and cytotoxicity of cyclophosphamide in primary cultures of postnatal rat hepatocytes. , 1981, Biochemical pharmacology.

[33]  D. Jollow,et al.  Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia. , 1988, The Journal of pharmacology and experimental therapeutics.

[34]  A. Buckpitt,et al.  Efflux of naphthalene oxide and reactive naphthalene metabolites from isolated hepatocytes. , 1987, The Journal of pharmacology and experimental therapeutics.

[35]  D. Liebler,et al.  Enzymatic activation of chemicals to toxic metabolites. , 1985, Critical reviews in toxicology.

[36]  P. Bk.  Metabolic Basis of Adverse Drug Reactions , 1986, Journal of the Royal College of Physicians of London.